Triple
T13959213
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Sinopharm |
E335747
|
entity |
| Predicate | hasSubsidiary |
P254
|
FINISHED |
| Object | China National Biotec Group |
E335747
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: China National Biotec Group | Statement: [Sinopharm, hasSubsidiary, China National Biotec Group]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: China National Biotec Group Context triple: [Sinopharm, hasSubsidiary, China National Biotec Group]
-
A.
Fosun Pharma
Fosun Pharma is a major Chinese pharmaceutical and healthcare company engaged in the research, development, manufacturing, and distribution of a wide range of medical products and services.
-
B.
Sinopharm
chosen
Sinopharm is a Chinese state-owned pharmaceutical company best known globally for developing and distributing inactivated COVID-19 vaccines.
-
C.
Fosun International
Fosun International is a major Chinese multinational conglomerate with diversified investments spanning sectors such as finance, healthcare, tourism, and consumer products.
-
D.
Chugai Pharmaceutical
Chugai Pharmaceutical is a major Japanese research-based pharmaceutical company known for its innovative biopharmaceuticals and strategic alliance with Roche.
-
E.
Mitsubishi Tanabe Pharma
Mitsubishi Tanabe Pharma is a Japanese pharmaceutical company known for developing prescription drugs and biopharmaceuticals, including treatments for neurological and autoimmune diseases.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d81c61f3508190aaf2ca0dc0002c59 |
completed | April 9, 2026, 9:38 p.m. |
| NER | Named-entity recognition | batch_69de2e7b2f908190aa32f22298964746 |
completed | April 14, 2026, 12:09 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69fba1d490048190b28cb44dd4ec46c4 |
completed | May 6, 2026, 8:17 p.m. |
Created at: April 9, 2026, 10:17 p.m.